Exclusive Interviews from
The Life Sciences Report

Novel Tools for Early Cancer Detection: Verisante Technologies Inc.


Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.
' target='_blank'>Build Biotech Wealth on Solid Platforms: Grant Zeng

Four Hidden Australian Life Sciences Growth Stocks Revealed: Scott Power


Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.
' target='_blank'>Gener8 Disrupts the Big Data Status Quo


Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.
' target='_blank'>Hang On, Folks—It's Going to Be a Bumpy Ride: 2014 Biotech Watchlist Update

Don't Miss the Boat on Big Biotech Catalysts: Keith Markey


Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.
' target='_blank'>Venture Capitalist Ran Nussbaum Brings Big Finance to Little Biotechs

Big Data Goes Hollywood: Alfred Maydorn

From Lab Bench to Bedside: David Lowe Brings Common Sense to Neuroscience Investing

Apply Market Savvy to Bear Market Debris; Uncover Biotech Treasures: Cleland and Ireland

Promising Biotechs Target New Ways to Kill Bad Bugs: Venture Capitalist Dennis Purcell

Exuberant, Yes: Michael King on How the Oncology Drug Development Machine Builds Biotech Wealth


Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.
' target='_blank'>Shining a Light on Overlooked and Underfollowed Biotechs: George Zavoico


Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.
' target='_blank'>Better, Faster, Cheaper—You Can Have All Three in Medtech: Ben Haynor


Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.
' target='_blank'>Bryan Brokmeier Remains Bullish on Life Sciences Tools and Diagnostics Companies


Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.
' target='_blank'>Evaluate Biotech Stocks with Cynicism: Debjit Chattopadhyay

Catalysts Drive These Stocks: Mara Goldstein

Biotech Showcase 2012
Gaurav Aggarwal, Panorama Capital; Steve Dunn, LifeTech Capital; Jonathan MacQuitty, Abingworth Management; Mark Barrett, Johnson & Johnson and Benjamin Perkins, Ernst & Young Capital Advisors discuss 'Redefining Exit Options Given the Current Economic Climate'

 

Life Sciences Summit 2011  James Sabry, MD, PhD, Genentech Inc.; Marc Tessier-Lavigne, PhD, The Rockefeller University; Bruce W. Stillman, PhD, Cold Spring Harbor Laboratory and George Scangos, PhD, Biogen Idec engaged in a thought provoking discussion during 'Evolution or Revolution? Transforming How Basic Research Discoveries Become Life Saving Therapies' plenary session

 

US-Japan Health Sciences Dialogue
Stephen Mahinka, Morgan, Lewis & Bockius; Tevi Troy, The Hudson Institute; Tomohiko Makino, Johns Hopkins School of Medicine; and Satoru Nagasaka, TMI Associates discuss 'New Government Policies and their Impact on Growth and Investment'

 

Conferences for the Life Sciences Industry

Demy-Colton Life Science Advisors is dedicated to producing highly specialized and targeted investor and business conferences exclusively for the biotechnology and life sciences industry. Demy-Colton has deep domain knowledge and a proven track record of designing and developing high-value added programs that meet and exceed the expectations of our participants.

Since its inception in 2009, Demy-Colton has co-founded the Biotech Showcase™, an investor conference that features 240 public and private presenting companies; it has been instrumental in re-launching the Life Sciences Summit™ an event dedicated to funding and partnering emerging biotech companies and innovations; and, it has expanded the US-Japan Health Sciences Dialogue™ into a global meeting focused on transpacific business development and investment.

Demy-Colton also offers partnering services through Demy-Colton Partnering, a highly intuitive online partnering and meeting management system.